Kaufen Sie noch für €99,00 ein und genießen Sie unseren kostenlosen Versand innerhalb Deutschland.
Hast du ein Konto?
Logge dich ein, damit es beim Checkout schneller geht.
Alle Gebühren werden in der aktuellen Währung (€) berechnet Deutschland (EUR €)
€0,00 EUR
SPARE 5% ab 50€ MBW mit dem Code 5WEED
Gewinne einen 100€ Gutschein auf Instagram!
Kostenloser Versand ab einem Bestellwert von 99€
OTT - SHOP
SKU:MS-YGCBD2-FEM-10
Y Griega CBD 2.0 is an improved version of Y Griega CBD offering better yields and a more complex terpene profile. The cross with Cherry Wine CBD has produced a new version in which all of the progeny have the high CBD, low THC property making it an ideal strain for all those who want it as an adjunct to other therapeutic treatments. this is a 50/50 indica/sativa hybrid.
Due to its very low THC levels it is suitable for all consumers, including older people and those with no previous tolerance or who have never previously had contact with any form of cannabis. The psychoactive effect it has is practically nil making it perfect for therapeutic oral consumption, whether via tinctures, butter, vegetable oils, etc.
Structurally it is similar to the first Y Griega CBD strain although it features improved production of both flowers and resin. In terms of aroma and flavour, it still has a clear citrus predominance but with added nuances of sweet, spiced wine. To achieve its maximum organoleptic performance, we recommend growing it organically.
In summary Y Griega CBD 2.0 is especially recommended for those who are not looking for a psycho-active high since the effect is of physically calming and soothing rather than cerebral.
SKU | MS-YGCBD2-FEM-10 |
---|---|
Brand/Breeder | Medical Seeds |
Variety | Medical Seeds |
THC-Gehalt | Minimal (0-4%) |
Ertrag | nan |
Erntezeit | nan |
Pflanzenhöhe | nan |
Effekte | Calming|Relaxing|Soothing |
Geschmack | nan |
Genetische Beschreibung | Y Griega X Cherry Wine CBD |
Blütezeit | nan |
Blüte Typ | Photoperiod |
Zucht | nan |
CBD | nan |
Pack Size |
10 Seeds |
---|
We use cookies to enhance your experience on our website.
Privacy & Policy